Action - ANOR

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Dernier

Prix Achat

Prix Vente

Volume échangé

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Clôture Veille

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

Genzyme Completes Tender Offer for Outstanding Shares of AnorMED

Acquisition to Strengthen Transplant and Oncology Businesses CAMBRIDGE, Mass. and VANCOUVER, B.C., Nov. 7 /PRNewswire-FirstCall/ -- Genzyme...

Genzyme and AnorMED Announce Completion of Hart-Scott-Rodino Review

CAMBRIDGE, Mass. and VANCOUVER, B.C., Nov. 7 /PRNewswire-FirstCall/ -- Genzyme Corporation (NASDAQ:GENZ) and AnorMED Inc. (Nasdaq: ANOR; TSX:...

AnorMED Reports Fiscal 2007 Second Quarter Results And An Update On Recent Corporate Events

AnorMED Board Recommends Shareholders Accept Genzyme Offer LANGLEY, BC, Nov. 3 /PRNewswire-FirstCall/ -- AnorMED Inc. ("AnorMED" or the...

Koronis Pharmaceuticals Appoints Stephen Becker, M.D., Chief Medical Officer

SEATTLE, Oct. 26 /PRNewswire/ -- Koronis Pharmaceuticals, Inc. today announced the appointment of Stephen Becker, M.D., as chief medical...

AnorMED completes enrollment in Phase III trial for MOZOBIL on schedule

VANCOUVER, Oct. 23 /PRNewswire-FirstCall/ -- AnorMED Inc. (NASDAQ:ANOR; TSX:AOM) today announced that it has completed enrollment in the second...

AnorMED and Genzyme reach agreement on acquisition

Genzyme to Gain Late-Stage Transplantation Product Candidate VANCOUVER, BC, and CAMBRIDGE, MA, Oct. 17 /PRNewswire-FirstCall/ -- Genzyme...

AnorMED has determined Genzyme's offer is a 'superior proposal'

Millennium has the right to match Genzyme's 'superior proposal' VANCOUVER, Oct. 11 /PRNewswire-FirstCall/ -- AnorMED Inc. ("AnorMED" or "the...

AnorMED has determined Genzyme's offer is a 'superior proposal'

Millennium has the right to match Genzyme's 'superior proposal' VANCOUVER, Oct. 11 /PRNewswire-FirstCall/ -- AnorMED Inc. ("AnorMED" or "the...

AnorMED announces receipt of proposal from Genzyme Corporation

VANCOUVER, Oct. 10 /PRNewswire-FirstCall/ -- AnorMED Inc. (NASDAQ:ANOR; TSX:AOM) announced today that it has received a proposal from Genzyme...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

ANOR - Frequently Asked Questions (FAQ)

What is the current share price?

The current share price of is US$ 0,00

What is the 1 year trading range for share price?

has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
PEVPhoenix Motor Inc	US$ 0,452 (79,29%)	32,99M
KELYBKelly Services Inc	US$ 21,78 (57,83%)	73
AIRTAir T Inc	US$ 30,99 (54,87%)	1
MBCNMiddlefield Banc Corporation	US$ 38,00 (52,00%)	209
ASPCA SPAC III Acquisition Corporation	US$ 15,00 (49,70%)	19
ROEEA Series Trust Astoria US Equal Weight Quality Kings ETF	US$ 15,01 (-52,21%)	3
CEFAGlobal X S&P Catholic Values Developed Ex US ETF	US$ 19,01 (-40,25%)	2
CLDXCelldex Therapeutics Inc	US$ 13,32 (-40,16%)	4
KTCCKeyTronic Corporation	US$ 2,01 (-38,15%)	1
CHCIComstock Holding Companies Inc	US$ 5,01 (-37,76%)	14
PEVPhoenix Motor Inc	US$ 0,4535 (79,89%)	33M
TIVCTivic Health Systems Inc	US$ 1,005 (43,57%)	13,72M
MGOLMGO Global Inc	US$ 0,6223 (36,38%)	13,32M
PRPHProPhase Labs Inc	US$ 0,3739 (33,30%)	7,82M
AVGRAvinger Inc	US$ 0,6557 (42,54%)	6,39M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Anormed Ord (MM) (ANOR)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

ANOR Dernières nouvelles

Genzyme Completes Tender Offer for Outstanding Shares of AnorMED

Genzyme and AnorMED Announce Completion of Hart-Scott-Rodino Review

AnorMED Reports Fiscal 2007 Second Quarter Results And An Update On Recent Corporate Events

Koronis Pharmaceuticals Appoints Stephen Becker, M.D., Chief Medical Officer

AnorMED completes enrollment in Phase III trial for MOZOBIL on schedule

AnorMED and Genzyme reach agreement on acquisition

AnorMED has determined Genzyme's offer is a 'superior proposal'

AnorMED has determined Genzyme's offer is a 'superior proposal'

AnorMED announces receipt of proposal from Genzyme Corporation

ANOR - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Anormed Ord (MM) (ANOR) Cours

Anormed Ord (MM) (ANOR)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

ANOR Dernières nouvelles

Genzyme Completes Tender Offer for Outstanding Shares of AnorMED

Genzyme and AnorMED Announce Completion of Hart-Scott-Rodino Review

AnorMED Reports Fiscal 2007 Second Quarter Results And An Update On Recent Corporate Events

Koronis Pharmaceuticals Appoints Stephen Becker, M.D., Chief Medical Officer

AnorMED completes enrollment in Phase III trial for MOZOBIL on schedule

AnorMED and Genzyme reach agreement on acquisition

AnorMED has determined Genzyme's offer is a 'superior proposal'

AnorMED has determined Genzyme's offer is a 'superior proposal'

AnorMED announces receipt of proposal from Genzyme Corporation

ANOR - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS